相关临床试验
0
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
暂无批准数据
- The University of Kansas Health System, University of Kansas Medical Center, Children's Mercy, and BAMF Health announced plans to establish one of the nation's first fully integrated theranostics platforms serving both adult and pediatric patients. - The collaboration will create a state-of-the-art facility housing radiopharmaceutical production, molecular imaging, radiopharmaceutical therapy, and radioligand clinical trials in one location. - Children's Mercy represents one of the first pediatric health systems to invest early in theranostics technology, ensuring children access to this precision medicine approach. - The platform will expand beyond current applications in metastatic prostate cancer and neuroendocrine cancer to include clinical trials for neurologic conditions such as Alzheimer's disease.
- Healthcare experts at PCOC meeting emphasize urgent need to align cancer care with value-based principles, addressing high treatment costs that limit access to life-saving therapies. - Dr. Keith Ferdinand advocates for holistic management of cardiovascular-kidney-metabolic syndrome, integrating social determinants of health into risk assessments and treatment plans. - Canadian study reveals significant variations in supportive care practices for elderly MDS/AML patients, highlighting need for standardized evidence-based guidelines.
